We have updated our Privacy Policy. Please review our Privacy Policy. This website uses cookies. By using our website without changing your cookie settings, you agree to our use of cookies as described in our Privacy Policy.

ONCE-MONTHLY VIVITROL ALONG WITH COUNSELING MAY GIVE YOU A PATH FORWARD IN YOUR alcohol dependence RECOVERY JOURNEY1

Continually facing the consequences of alcohol dependence can be a challenge, but you are not alone. VIVITROL and counseling may be able to help.

VIVITROL and counseling have been shown to reduce the number of heavy drinking days* in patients with alcohol dependence1,2

In a 24-week, double-blind, placebo-controlled clinical study, patients with alcohol dependence in an outpatient setting treated with VIVITROL and counseling reported 25% fewer heavy drinking days* per month than those treated with placebo and counseling.

*Heavy drinking days were defined as 5 or more drinks per day for men and 4 or more drinks per day for women.

In the same study, data on abstinence from drinking were obtained in a small subset of patients1,2

This same clinical study included a subset of VIVITROL and placebo patients (8% of the total study population) who abstained from alcohol completely during the week prior to their first dose. The patients in the VIVITROL group were more likely to maintain complete abstinence vs the placebo group to the end of the 24-week trial. The same result was not seen in patients who were still drinking at the start of the trial.

VIVITROL is a once-monthly injection1

Your recovery journey is worth fighting for. Ask your healthcare provider if once-monthly VIVITROL may be right for you.


SETTING TREATMENT GOALS FOR YOUR RECOVERY JOURNEY

On the road to recovery, there may be challenges along the way. Revisiting treatment goals with your doctor may help you stay motivated in your recovery.3

start now

NEED HELP PREPARING FOR TREATMENT?

These tips may help you prepare for your VIVITROL injection.

Learn more

VIVITROL is not right for everyone. There are significant risks from VIVITROL treatment, including risk of opioid overdose, severe reaction at the injection site, sudden opioid withdrawal, liver damage, or hepatitis.

Talk to your healthcare provider about naloxone, a medicine that is available to patients for the emergency treatment of an opioid overdose.

Call 911 or get emergency medical help right away in all cases of known or suspected opioid overdose, even if naloxone is administered.

If you are being treated for alcohol dependence but also use or are addicted to opioid-containing medicines or opioid street drugs, it is important that you tell your healthcare provider before starting VIVITROL to avoid having sudden opioid withdrawal symptoms when you start VIVITROL treatment.

See Important Safety Information.

See Prescribing Information and Medication Guide.


References: 1. VIVITROL [prescribing information]. Waltham, MA: Alkermes, Inc; rev March 2021. 2. Garbutt JC, Kranzler HR, O’Malley SS, et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005;293(13):1617-1625. 3. Substance Abuse and Mental Health Services Administration (SAMHSA). Enhancing motivation for change in substance use disorder treatment. Treatment Improvement Protocol (TIP) 35. SAMHSA Publication No. EP19-02-01-003. Printed 2019.

References: 1. VIVITROL [prescribing information]. Waltham, MA: Alkermes, Inc; rev March 2021. 2. Garbutt JC, Kranzler HR, O’Malley SS, et al. Efficacy and tolerability of long-acting injectable naltrexone for alcohol dependence: a randomized controlled trial. JAMA. 2005;293(13):1617-1625. 3. Substance Abuse and Mental Health Services Administration (SAMHSA). Enhancing motivation for change in substance use disorder treatment. Treatment Improvement Protocol (TIP) 35. SAMHSA Publication No. EP19-02-01-003. Printed 2019.